Analysis of the Food and Drug Administration Adverse Event Reporting System to Examine the Relationship between Tumor Necrosis Factor Alpha Inhibitor Therapy and Congestive Heart Failure among Patients with Inflammatory Bowel Disease

被引：0
|
作者：
Deepak, Parakkal [1 ]
Stobaugh, Derrick [1 ]
Ehrenpreis, Eli [1 ]
机构：
[1] NorthShore Univ HealthSyst, Evanston, IL USA
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2013年 / 108卷
关键词：
D O I：
10.14309/00000434-201310001-01726
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1726
引用
收藏
页码：S520 / S521
页数：2
相关论文
共 39 条
  • [31] Tumor Necrosis Factor-alpha Blocker Monotherapy or In Combination with Immunomodulators or Systemic Corticosteroids Does not Augment the Risk of Bacterial Infections: A Review of the Food and Drug Administration Adverse Event Reporting System (FDA AERS)
    Deepak, Parakkal
    Stobaugh, Derrick
    Ehrenpreis, Eli
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2012, 107 : S650 - S650
  • [32] Frequency of Reported Euglycemic Ketoacidosis With SodiumGlucose Cotransporter-2 Inhibitors is Not Increased in Patients With Heart Failure: Analysis of US Food and Drug Administration Adverse Event Reporting System (FAERS)
    Yeung, Samantha L.
    Wang, Mengxi
    Lou, Mimi
    Ng, Tien M.
    [J]. CIRCULATION, 2023, 148
  • [33] Deaths and vascular outcomes with non-vitamin K oral anticoagulants versus warfarin in patients with heart failure in the food and drug administration adverse event reporting system
    Von Lueder, T. A.
    Atar, D.
    Agewall, S.
    Jensen, J.
    Hopper, I.
    Kotecha, D.
    Mentz, R.
    Serebruany, V. L.
    [J]. EUROPEAN HEART JOURNAL, 2018, 39 : 380 - 380
  • [34] Potential safety signal of pregnancy loss with vascular endothelial growth factor inhibitor intraocular injection: A disproportionality analysis using the Food and Drug Administration Adverse Event Reporting System
    Sakai, Takamasa
    Mori, Chiyo
    Ohtsu, Fumiko
    [J]. FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [35] Association between preoperative tumor necrosis factor alpha inhibitor and surgical site infection after surgery for inflammatory bowel disease: a systematic review and meta-analysis
    Uchino, Motoi
    Ikeuchi, Hiroki
    Shimizu, Junzo
    Ohge, Hiroki
    Haji, Seiji
    Mizuguchi, Toru
    Mohri, Yasuhiko
    Yamashita, Chizuru
    Kitagawa, Yuichi
    Suzuki, Katsunori
    Kobayashi, Motomu
    Kobayashi, Masahiro
    Sakamoto, Fumie
    Yoshida, Masahiro
    Mayumi, Toshihiko
    Hirata, Koichi
    Takesue, Yoshio
    [J]. SURGERY TODAY, 2021, 51 (01) : 32 - 43
  • [36] Association between preoperative tumor necrosis factor alpha inhibitor and surgical site infection after surgery for inflammatory bowel disease: a systematic review and meta-analysis
    Motoi Uchino
    Hiroki Ikeuchi
    Junzo Shimizu
    Hiroki Ohge
    Seiji Haji
    Toru Mizuguchi
    Yasuhiko Mohri
    Chizuru Yamashita
    Yuichi Kitagawa
    Katsunori Suzuki
    Motomu Kobayashi
    Masahiro Kobayashi
    Fumie Sakamoto
    Masahiro Yoshida
    Toshihiko Mayumi
    Koichi Hirata
    Yoshio Takesue
    [J]. Surgery Today, 2021, 51 : 32 - 43
  • [37] Incidence of Selected Adverse Events (AES) in Inflammatory Bowel Disease (IBD) Patients With and Without Exposure to Anti-Tumor Necrosis Factor Alpha (Anti-TNFα) Therapy
    McAuliffe, Megan E.
    Leach, Tim
    Fox, Irving
    Lanes, Stephan
    Faich, Gerald
    Porter, Jane
    Zhao, Yueqin
    Parikh, Asit
    [J]. GASTROENTEROLOGY, 2012, 142 (05) : S664 - S664
  • [38] All-Cause Mortality and Cardiovascular Outcomes With Non-Vitamin K Oral Anticoagulants Versus Warfarin in Patients With Heart Failure in the Food and Drug Administration Adverse Event Reporting System
    von Lueder, Thomas G.
    Atar, Dan
    Agewall, Stefan
    Jensen, Jesper K.
    Hopper, Ingrid
    Kotecha, Dipak
    Mentz, Robert J.
    Kim, Moo Hyun
    Serebruany, Victor L.
    [J]. AMERICAN JOURNAL OF THERAPEUTICS, 2019, 26 (06) : E671 - E678
  • [39] Age-related trends in injection site reaction incidence induced by the tumor necrosis factor-α (TNF-α) inhibitors etanercept and adalimumab: the Food and Drug Administration adverse event reporting system, 2004-2015
    Matsui, Toshinobu
    Umetsu, Ryogo
    Kato, Yamato
    Hane, Yuuki
    Sasaoka, Sayaka
    Motooka, Yumi
    Hatahira, Haruna
    Abe, Junko
    Fukuda, Akiho
    Naganuma, Misa
    Kinosada, Yasutomi
    Nakamura, Mitsuhiro
    [J]. INTERNATIONAL JOURNAL OF MEDICAL SCIENCES, 2017, 14 (02): : 102 - 109
1234